Invest now
Viyash Scientific Ltd share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹265.40(1.86%)September 4, 2026 15:57:22 PM IST
- NSE
- BSE
- Vol : 3.47 M (NSE + BSE)Last 20 day avg : 10.70 M
Viyash Scientific Ltd is trading 1.86% upper at Rs 265.40 as compared to its last closing price. Viyash Scientific Ltd has been trading in the price range of 268.10 & 260.70. Viyash Scientific Ltd has given 24.89% in this year & 0.37% in the last 5 days. Viyash Scientific Ltd has TTM P/E ratio 66.48 as compared to the sector P/E of 37.27.There are 3 analysts who have initiated coverage on Viyash Scientific Ltd. There are 3 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 65.87 Crores in its last quarter.Listed peers of Viyash Scientific Ltd include Sun Pharmaceutical Industries (-0.26%), Divi's Laboratories (-1.57%), Torrent Pharmaceuticals (-1.52%).The Mutual Fund holding in Viyash Scientific Ltd was at 2.93% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Viyash Scientific Ltd was at 4.50% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 05 Sep 2026, 08:51 PM IST
- BetaHigh volatility1.76Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.17The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation77.76The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Viyash Scientific Ltd News
Viyash Scientific Ltd Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,899.00 | -0.26 | 4,55,622.97 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,100.00 | -1.57 | 2,41,576.41 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,850.00 | -1.52 | 1,84,471.81 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,385.00 | -0.29 | 1,11,887.66 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,121.00 | -1.23 | 1,11,820.18 | 21.19 | 4.24 | 0.09 | 14.22 |
Viyash Scientific Ltd Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
About the company Viyash Scientific Ltd
- IndustryBiotechnology & Drugs
- ISININE807F01027
- BSE Code512529
- NSE CodeVIYASH
Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.
Viyash Scientific Ltd Share Price FAQs
Viyash Scientific Ltd is trading at 265.40 as on Fri Sep 04 2026 10:27:22. This is 1.86% upper as compared to its previous closing price of 260.55.
The market capitalization of Viyash Scientific Ltd is 11675.15 Cr as on Fri Sep 04 2026 10:27:22.
The average broker rating on Viyash Scientific Ltd is Strong Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Viyash Scientific Ltd is 297.90 whereas the 52 wk low is 168.35
Viyash Scientific Ltd can be analyzed on the following key metrics -
- TTM P/E: 66.48
- Sector P/E: 37.27
- Dividend Yield: 0.00%
- D/E ratio: -
Viyash Scientific Ltd reported a net profit of 177.29 Cr in 2026.
The Mutual Fund Shareholding was 2.93% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Viyash Scientific Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.